N-Glycosylation Modification of Plant-Derived Virus-Like Particles: An Application in Vaccines
- Authors
- Kim, Hyun-Soon; Jeon, Jae-Heung; Lee, Kyung Jin; Ko, Kisung
- Issue Date
- 2014
- Publisher
- HINDAWI LTD
- Citation
- BIOMED RESEARCH INTERNATIONAL, v.2014
- Journal Title
- BIOMED RESEARCH INTERNATIONAL
- Volume
- 2014
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/13955
- DOI
- 10.1155/2014/249519
- ISSN
- 2314-6133
2314-6141
- Abstract
- Plants have been developed as an alternative system to mammalian cells for production of recombinant prophylactic or therapeutic proteins for human and animal use. Effective plant expression systems for recombinant proteins have been established with the optimal combination of gene expression regulatory elements and control of posttranslational processing of recombinant glycoproteins. In plant, virus-like particles (VLPs), viral "empty shells" which maintain the same structural characteristics of virions but are genome-free, are considered extremely promising as vaccine platforms and therapeutic delivery systems. Unlike microbial fermentation, plants are capable of carrying out N-glycosylation as a posttranslational modification of glycoproteins. Recent advances in the glycoengineering in plant allow human-like glycomodification and optimization of desired glycan structures for enhancing safety and functionality of recombinant pharmaceutical glycoproteins. In this review, the current plant-derived VLP approaches are focused, and N-glycosylation and its in planta modifications are discussed.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.